BackSyra Health Overview
Syra Health Corp - Ordinary Shares - Class A

Syra Health Return on Equity

Valuation check: SYRA's ROE is 4.96%, above the sector sector average of -5.93%.

Get informed when a big investor buys or sells

+ Follow

ROE

4.96%

Return on Equity

4.96%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

Syra Health (SYRA) FAQ

Syra Health (SYRA) currently reports a ROE of 4.96%. That is above the sector sector average of -5.93%. Use the charts on this page to explore Syra Health's ROE history and peer comparisons.

Syra Health's ROE of 4.96% is higher than the its sector sector average of -5.93%. That is roughly 183.7% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Syra Health's current 4.96% should be judged against industry norms (sector average: -5.93%) and against SYRA's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of 4.96%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is -5.93%. From there, open related valuation or income-statement pages for Syra Health, and consider following SYRA for alerts when major investors trade the stock.